Execution trajectory for market dominance.
Corporate incorporation, seed funding closure, and securing flagship location lease.
High-spec renovation, medical equipment procurement, and AVS licensing.
Opening of Location #1. Onboarding inaugural cohort of vet partners.
Ramping utilization to 60%. Scouting Locations #2 and #3.
Launch of Locations #2, #3, #4. Consolidated EBITDA run-rate >S$5M p.a.